z-logo
open-access-imgOpen Access
Cost-effectiveness analysis of durvalumab as a maintenance treatment for patients with locally advanced, unresectable, stage Ⅲ nsclc in china
Author(s) -
Xiaotong Jiang,
Jinyu Chen,
Min Zheng,
Hanxue Jia
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0270118
Subject(s) - durvalumab , stage (stratigraphy) , china , medicine , oncology , cancer , geography , biology , nivolumab , paleontology , immunotherapy , archaeology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom